Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
about
Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cellsPhase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphomaTumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivoFuture of idiotypic vaccination for B-cell lymphoma.Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccinesFollicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapyLymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant.Idiotype vaccine strategies for treatment of follicular lymphoma.Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.What influence has B-cell depletion on viral infections?Importance of [18F]fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma.
P2860
Q24658494-6EA260FB-D0F6-4B87-A63A-B6EBB9DCC047Q33386521-67C19378-0C8E-4A26-9233-F35D9D234493Q33814247-0EDADDA1-95C5-48A7-9D43-F23251ADA63BQ34038839-2A269F27-282A-406A-9A99-28C4EC563D0DQ36407174-65D3CA09-315D-4573-8159-FBF2AF64478CQ37354174-70BEA617-A167-439E-BC39-63DDBBEAD2C7Q37401011-861221D3-8183-464A-B9B6-0460DBBC6B66Q37427993-A3450671-295B-4559-9041-C66404690107Q37773301-44A961E2-270D-480F-AB1D-BBE1266A2409Q37822740-964ACC76-5B76-47B5-B3EF-14A45C4E8B9CQ37824996-7B22355A-EA28-49B2-9E86-44A7B3B4AA4AQ40030430-FAAB057C-9D07-498E-85D0-E2C4D9B52A5DQ45869394-6F800045-043B-4461-9006-967304636F64Q53497334-601FFFAE-AC0F-4D40-BE67-09881F92E74A
P2860
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
@ast
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
@en
type
label
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
@ast
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
@en
prefLabel
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
@ast
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
@en
P1476
Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
@en
P2093
John M Timmerman
Sara A Hurvitz
P304
P356
10.1097/01.CCO.0000174040.52427.83
P577
2005-09-01T00:00:00Z